Teza Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-2,561
Closed -$351K – 628
2024
Q2
$351K Sell
2,561
-2,877
-53% -$394K 0.04% 422
2024
Q1
$724K Buy
+5,438
New +$706K 0.1% 271
2023
Q4
– Sell
-5,599
Closed -$682K – 601
2023
Q3
$682K Buy
5,599
+421
+8% +$56.1K 0.11% 259
2023
Q2
$728K Buy
+5,178
New +$714K 0.12% 237
2023
Q1
– Sell
-1,845
Closed -$289K – 550
2022
Q4
$289K Sell
1,845
-1,839
-50% -$264K 0.05% 452
2022
Q3
$452K Sell
3,684
-1,031
-22% -$136K 0.09% 311
2022
Q2
$627K Buy
+4,715
New +$642K 0.24% 150
2022
Q1
– Sell
-1,528
Closed -$264K – 434
2021
Q4
$264K Sell
1,528
-8,544
-85% -$1.3M 0.07% 348
2021
Q3
$1.46M Buy
+10,072
New +$1.47M 0.7% 31
2021
Q1
– Sell
-1,758
Closed -$210K – 486
2020
Q4
$210K Buy
+1,758
New +$214K 0.12% 252
2020
Q3
– Sell
-13,889
Closed -$1.58M – 434
2020
Q2
$1.58M Buy
+13,889
New +$1.47M 0.35% 69
2020
Q1
– Sell
-2,008
Closed -$214K – 220
2019
Q4
$214K Buy
+2,008
New +$209K 0.06% 497
2019
Q3
– Sell
-3,798
Closed -$387K – 524
2019
Q2
$387K Buy
+3,798
New +$365K 0.23% 155
2018
Q2
– Sell
-3,816
Closed -$383K – 487
2018
Q1
$383K Buy
+3,816
New +$391K 0.09% 335

Other funds holding DGX

Teza Capital Management's DGX Position: Q3 2024 in Review

Teza Capital Management sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 2,561 shares — an estimated $351K sold.

Teza Capital Management first reported a position in DGX in Q1 2018 and held it in 14 quarters. The position peaked at $1.58M in Q2 2020. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • Teza Capital Management reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
  • Teza Capital Management sold 2,561 Quest Diagnostics shares in Q3 2024, an estimated $351K.
  • Teza Capital Management first reported a position in Quest Diagnostics in Q1 2018 and held it in 14 quarters.
  • Teza Capital Management's Quest Diagnostics position peaked at $1.58M in Q2 2020.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on Teza Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.